Related Experiment Video

Updated: Sep 27, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Surgical treatment of malignant pleural mesothelioma: a review

Serge van Ruth1, Paul Baas, Frans A N Zoetmulder

  • 1Department of Surgical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. s.v.ruth@nki.nl

Chest
|February 11, 2003
PubMed

Insights

Malignant pleural mesothelioma (MPM) lacks effective treatments, with poor prognosis. This review focuses on the current state of surgical management and adjuvant therapies for MPM, aiming to improve patient outcomes.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Malignant Pleural Mesothelioma Research

Background:

  • Malignant pleural mesothelioma (MPM) remains an aggressive cancer with no consistently effective therapies.
  • Current treatments like chemotherapy and radiotherapy offer limited long-term benefits for MPM patients.
  • MPM is typically localized to the pleura initially, suggesting local treatment approaches are rational.

Purpose of the Study:

  • To review the current status of surgical management for malignant pleural mesothelioma.
  • To explore the role of surgery in combination with adjuvant therapies for MPM.
  • To provide an overview of recent advancements in the surgical treatment of MPM.

Main Methods:

  • Review of existing literature on surgical management of MPM.
  • Analysis of outcomes for surgery alone versus combined-modality treatments.
  • Evaluation of adjuvant therapies used in conjunction with surgical resection for MPM.

Main Results:

  • Surgery alone for MPM is associated with high recurrence rates and uncertain survival benefits.
  • Combining surgical resection with adjuvant therapies is an increasing focus in MPM treatment.
  • The optimal surgical approach and adjuvant strategy for MPM are still under investigation.

Conclusions:

  • Effective therapies for malignant pleural mesothelioma are still lacking.
  • Surgical management, particularly when combined with adjuvant treatments, is a critical area of focus for improving MPM outcomes.
  • Further research is needed to optimize surgical and adjuvant strategies for MPM.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations: